Chest Radiology: Page 152

ASTRO: High-dose RT doesn't improve survival in NSCLC patients
By Cynthia E. Keen
MIAMI BEACH, Fla. - High-dose radiation therapy (RT) doesn't improve survival for advanced non-small cell lung cancer (NSCLC) patients, and the treatment used for the past 30 years should continue to be used, according to results presented on Monday at the American Society for Radiation Oncology (ASTRO) annual meeting.
October 2, 2011
Calypso obtains IDE approval
By AuntMinnie.com staff writers
Electromagnetic localization technology developer Calypso Medical Technologies has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration for a clinical study evaluating real-time tracking of lung cancer tumors during radiation delivery.
September 28, 2011
CT radiation may pose lower cancer risk for sicker patients
By Eric Barnes
Patients with shorter life expectancies are at far less risk relative to those with a good prognosis when it comes to radiation dangers from medical imaging, conclude researchers in a new study in Radiology. The results may bring some relief to radiologists who feel that radiation risk has been overemphasized at the expense of clinical need.
September 27, 2011
2011 09 28 09 12 57 302 Brenner fig1
NLST analysis to yield key cost data on CT lung screening
By Eric Barnes
Now that a major study has shown that lung cancer screening reduces mortality, healthcare payors want to find out if it's cost-effective -- and they'll soon know the answer, according to a presentation at last week's American College of Radiology Imaging Network fall meeting in Arlington, VA.
September 25, 2011
Bionix adds Medspira's Breath Hold
By AuntMinnie.com staff writers
Radiation therapy accessories provider Bionix Radiation Therapy has added Breath Hold, an interactive breath-hold control monitoring system from Medspira, as an accessory to its Omni V patient positioning system.
September 20, 2011
Concurrent chemo + RT improves survival for inoperable NSCLC
By Cynthia E. Keen
Chemotherapy delivered concurrently with radiation therapy (RT) is more effective than treatments delivered sequentially for extending the lives of patients with inoperable stage III non-small cell lung cancer (NSCLC), according to a study published online September 8 in the Journal of the National Cancer Institute.
September 8, 2011
JACR: Experts point the way to low-dose chest CT
By Eric Barnes
A new article in the September issue of the Journal of the American College of Radiology offers pointers for optimizing radiation dose in chest CT scans, the third most commonly performed CT exam in the U.S.
August 31, 2011
MRI ADC values can help predict NSCLC prognosis
By Wayne Forrest
Apparent diffusion coefficient (ADC) values generated by MRI scans may be a promising tool to monitor early response and predict prognosis after chemotherapy for non-small cell lung cancer (NSCLC), according to a study published online August 18 in Radiology.
August 31, 2011
2011 08 31 13 33 47 508 2011 08 31 Adc Mri Thumb
Researchers cut CT dose for nodule follow-up
By Eric Barnes
For surveillance of previously detected lung nodules, CT radiation dose can be cut to approximately 3% of the original exam dose, concludes a new study in the September edition of the American Journal of Roentgenology.
August 22, 2011
SPECT tracer could cut staging costs for NSCLC
By Tami Freeman
There may be an alternative to non-small cell lung cancer (NSCLC) diagnosis and staging using FDG-PET: low-cost SPECT imaging with a new molecular imaging agent, according to research from MD Anderson Cancer Center and biopharmaceutical company Cell>Point.
August 5, 2011
2011 08 05 10 31 37 792 Spect Nsclc Md Anderson Thumb
Quantitative CT links COPD type and severity with flare-ups
By Eric Barnes
CT can detect both the type and severity of chronic obstructive pulmonary disease (COPD), helping predict which patients will experience exacerbations, according to a new study published online in Radiology.
July 28, 2011
2011 07 29 12 33 28 447 Han thumb 08 Comp
Elekta touts SBRT research
By AuntMinnie.com staff writers
Oncology firm Elekta said that recent research from Princess Margaret Hospital in Toronto showed favorable clinical results from treating early-stage, non-small cell lung cancer with its stereotactic body radiation therapy (SBRT) technology.
July 19, 2011
Previous Page
Page 152 of 208
Next Page